Today, Cochrane Review released a systematic review update on using e-cigarettes to quit smoking. The update included findings from 17 new studies which provided further evidence that e-cigarettes are a more effective tool than traditional nicotine replacement therapies (NRTs) for smoking cessation.
The Cochrane Review is a respected standard in the medical community, summarizing and explaining scientific and medical research while also providing commentary and meta-analyses on key scientific issues. Their latest report examines the effectiveness, tolerance, and safety of e-cigarettes in aiding smokers to quit. The review analyzed a total of 78 studies, which included 22,052 participants. Of those studies, 40 were randomized controlled trials.
The main findings and conclusions of the Cochrane Review are as follows:
There is "significant and reliable evidence" indicating that electronic cigarettes containing nicotine can increase the likelihood for smokers to successfully quit smoking long-term compared to traditional nicotine replacement therapies.
For every 100 people attempting to quit smoking, e-cigarettes can help an additional four individuals quit compared to traditional nicotine replacement therapy (NRT) users.
Evidence also suggests that nicotine e-cigarettes may be more beneficial for people trying to quit smoking than behavioral support, but researchers believe that this evidence still needs to be confirmed.
According to researchers, there is no evidence that e-cigarettes pose a "serious harm".
According to the results of the Cochrane Review, electronic cigarettes can play a critical role in transitioning several generations of cigarette smokers to low-risk nicotine products. The likelihood of completely quitting smoking increases by 43% when comparing those who use flavorless or tobacco-flavored electronic cigarette products, not including other flavors.
The original report can be viewed by clicking on the link: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub7/full.
Statement:
This article is compiled from information provided by a third party and is intended for industry professionals for educational and informational purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The translation of this article is solely for industry exchange and research purposes.
Due to limitations in our ability to translate accurately, this article may not convey the exact same meaning as the original. Please refer to the original text for the most accurate information.
2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.
All compiled information is owned by the original media and authors. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
